The new vaccine is a combination of GSK’s already-approved vaccines Bexsero and Menveo and is designed to protect against meningitis and blood poisoning caused by the A, B, C, W, and Y ...

Scientific Conference by GlaxoSmithKline on the Launch of “Bexsero,” Egypt’s First Vaccine for the Prevention of Meningococcal Bacterial Meningitis (Group B) Sunday 13 Apr 2025 ...

After months of delay, GlaxoSmithKline has agreed a deal with the UK government that will allow its meningitis B (MenB) vaccine Bexsero to be added to the NHS' routine childhood immunisation schedule.